• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Blue Bird Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

    5/12/23 8:20:10 AM ET
    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $ADXN alert in real time by email

    Gainers

    • Getaround, Inc. (NYSE:GETR) shares surged 112% to $0.7020 in pre-market trading. Getaround acquired substantially all assets of HyreCar for an aggregate purchase price of $9.45 million.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares rose 35.2% to $2.61 in pre-market trading after the company highlighted recent corporate progress, and reported financial results for the first quarter.
    • Blue Bird Corporation (NASDAQ:BLBD) shares gained 30% to $25.16 in pre-market trading after the company reported better-than-expected Q2 results.
    • Rubicon Technologies, Inc. (NYSE:RBT) shares rose 19.5% to $0.5340 in pre-market trading after dropping around 15% on Thursday.
    • Momentus Inc. (NASDAQ:MNTS) shares gained 18.5% to $0.4979 in pre-market trading following Q1 results.
    • Babylon Holdings Limited (NYSE:BBLN) shares climbed 16% to $1.38 in pre-market trading after dropping 42% on Thursday. Babylon recently reported mixed Q1 financial results. The company also announced it secured financing and plans to implement a take private transaction with support from AlbaCore Capital.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) rose 13.4% to $1.34 in pre-market trading following better-than-expected quarterly sales.
    • Intelligent Bio Solutions Inc. (NASDAQ:INBS) gained 12.5% to $3.39 in pre-market trading after reporting Q3 results.
    • OppFi Inc. (NYSE:OPFI) rose 12.2% to $2.30 in pre-market trading as the company posted upbeat Q1 results and raised FY23 EPS guidance.
    • Ouster, Inc. (NYSE:OUST) gained 11.5% to $4.28 in pre-market trading following strong Q1 sales results.

    Losers

    • VirnetX Holding Corporation (NYSE:VHC) fell 19.6% to $0.35 in pre-market after gaining around 15% on Thursday. VirnetX recently announced a partnership with Samsung.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares dropped 14.7% to $0.6824 in pre-market trading. A 13D filing recently showed Baker Bros. Advisors reported a 19.99% active stake in the company.
    • VCI Global Limited (NASDAQ:VCIG) fell 11.1% to $3.13 in pre-market trading after gaining over 8% on Thursday. VCI Global announced application for dual listing on upstream.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) shares fell 11% to $0.7915 in pre-market trading. Addex Therapeutics shares dropped around 6% on Thursday after the company reported Q1 financial results.
    • MMTec, Inc. (NASDAQ:MTC) fell 10.7% to $0.9808 in pre-market trading after gaining more than 5% on Thursday.
    • Austin Gold Corp. (NYSE:AUST) fell 10.2% to $1.06 in pre-market trading. Austin Gold reported the results of the 2023 Annual General Meeting.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 9.8% to $1.74 in pre-market trading after jumping 18% on Thursday. Assure Holdings recently reported preliminary first quarter 2023 financial results.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) fell 9.1% to $1.00 in pre-market trading. Red Cat recently received order for 200 long-range, high-speed drones for Ukrainian deployment.
    • Unique Fabricating, Inc. (NASDAQ:UFAB) fell 8.8% to $0.2418 in pre-market trading after dropping 16% on Thursday.
    • BIOLASE, Inc. (NASDAQ:BIOL) shares dropped 8.3% to $0.22 in pre-market trading after the company posted Q1 results.

     

    Now Read This: Investor Sentiment Declines Further After Dow Drops For Fourth Consecutive Day

    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $BBLN
    $BIOL
    $BLBD

    CompanyDatePrice TargetRatingAnalyst
    Cidara Therapeutics Inc.
    $CDTX
    11/17/2025Overweight → Equal-Weight
    Morgan Stanley
    Cidara Therapeutics Inc.
    $CDTX
    11/17/2025Overweight → Neutral
    Analyst
    Cidara Therapeutics Inc.
    $CDTX
    11/17/2025Outperform → Sector Perform
    RBC Capital Mkts
    Ouster Inc.
    $OUST
    11/7/2025$33.00Neutral → Overweight
    Cantor Fitzgerald
    Cidara Therapeutics Inc.
    $CDTX
    10/16/2025$190.00Overweight
    Morgan Stanley
    Cidara Therapeutics Inc.
    $CDTX
    10/10/2025$200.00Overweight
    Analyst
    Red Cat Holdings Inc.
    $RCAT
    10/3/2025$17.00Buy
    Needham
    Cidara Therapeutics Inc.
    $CDTX
    6/18/2025$41.00Buy
    H.C. Wainwright
    More analyst ratings

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boulet Virginia bought $136,175 worth of shares (6,500 units at $20.95), increasing direct ownership by 3% to 228,342 units (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/9/26 7:35:06 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Chief Operating Officer Sanfrey Jeffrey Scott exercised 5,192 shares at a strike of $12.35 and sold $303,940 worth of shares (5,192 units at $58.54) (SEC Form 4)

    4 - Blue Bird Corp (0001589526) (Issuer)

    3/5/26 10:44:56 AM ET
    $BLBD
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    SEC Form 4 filed by Chief Technology Officer Schwarz Robert E

    4 - Momentus Inc. (0001781162) (Issuer)

    3/3/26 6:58:28 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boulet Virginia bought $136,175 worth of shares (6,500 units at $20.95), increasing direct ownership by 3% to 228,342 units (SEC Form 4)

    4 - Ouster, Inc. (0001816581) (Issuer)

    3/9/26 7:35:06 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    President & CEO Stein Jeffrey disposed of $339,040 worth of shares (5,190 units at $65.33), bought $339,040 worth of shares (4,262 units at $79.55), gifted 1,873 shares and received a gift of 937 shares, decreasing direct ownership by 44% to 5,763 units (SEC Form 4)

    4 - Cidara Therapeutics, Inc. (0001610618) (Issuer)

    1/7/26 8:12:25 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Thau Daniel Mark bought $20,420 worth of shares (400 units at $51.05), increasing direct ownership by 7% to 6,099 units (SEC Form 4)

    4 - Blue Bird Corp (0001589526) (Issuer)

    12/5/25 9:28:38 AM ET
    $BLBD
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    SEC Filings

    View All

    SEC Form 6-K filed by VCI Global Limited

    6-K - VCI Global Ltd (0001930510) (Filer)

    3/9/26 10:31:15 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 424B5 filed by VCI Global Limited

    424B5 - VCI Global Ltd (0001930510) (Filer)

    3/6/26 3:10:45 PM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    SEC Form 6-K filed by VCI Global Limited

    6-K - VCI Global Ltd (0001930510) (Filer)

    3/3/26 4:05:05 PM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cidara Therapeutics downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded Cidara Therapeutics from Outperform to Sector Perform

    11/17/25 9:39:33 AM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cidara Therapeutics downgraded by Analyst

    Analyst downgraded Cidara Therapeutics from Overweight to Neutral

    11/17/25 9:39:33 AM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cidara Therapeutics downgraded by Morgan Stanley

    Morgan Stanley downgraded Cidara Therapeutics from Overweight to Equal-Weight

    11/17/25 9:39:33 AM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VCI Global Announces US$5 Million Institutional Registered Direct Offering

    KUALA LUMPUR, Malaysia, March 06, 2026 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ:VCIG) ("VCI Global" or the "Company"), today announced that it has entered into a definitive agreement with Esousa Group Holdings LLC, a New York-based family office, for the issuance and sale of the Company's ordinary shares and warrants in a registered direct offering. The offering is structured in multiple tranches, with the initial tranche expected to generate aggregate gross proceed of US$5 Million before deducting placement agent fees and other offering expenses. Pursuant to the terms of the agreement, the initial closing is expected to occur on or about March 6, 2026, subject to the satisfaction o

    3/6/26 9:15:00 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Defense Drone Market Accelerates Toward $40B+ Opportunity as Autonomous Warfare Redefines Modern Battlefields

    NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lately, military drones have gone way beyond hobby-store quadcopters. Modern defense drones now include AI-powered autonomous systems that can scout, target, loiter for hours, or even work in swarms without a pilot sitting nearby. Countries and defense startups are racing to build everything from tiny reconnaissance birds to long-range strike UAVs, and even counter-drone weapons like lasers and high-power radar to deal with swarms in real time. This push isn't just for show — global tensions and real combat experience are driving huge interest in these machines, with companies like Anduril pulling in massive

    3/5/26 9:25:00 AM ET
    $AIRO
    $ONDS
    $RCAT
    Aerospace
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Ouster Accelerates Software Adoption in 2025 with Record Bookings and Global Expansion

    Doubled software-attached bookings in 2025 and expanded contracted deployments for Ouster Gemini and Ouster BlueCity to more than 1,200 sites spanning over 65 million square feet of roadways and facilities Awarded contract to provide intelligent signal actuation at over 100 intersections in Nashville, TN Brought lidar-powered Physical AI solutions to cities and enterprises worldwide using NVIDIA Metropolis and the NVIDIA Jetson platform Advanced AI capabilities and introduced new cloud tools to scale enterprise deployments Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, today announced significant commercial momentum f

    3/5/26 6:00:00 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Financials

    Live finance-specific insights

    View All

    Ouster Announces Results for Fourth Quarter and Full Year 2025

    Record revenue and gross margins, achieving 12th straight quarter of product revenue growth Record quarterly lidar shipments of 8,100 units; 2025 shipments exceed 25,000 Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today financial results for the three months and year ended December 31, 2025. "2025 was a year of exceptional execution for Ouster. Our strong revenue growth and gross margin performance are a testament to our disciplined focus as we pioneer the technologies driving the secular shift towards Physical AI, delivering record results," said Ouster CEO Angus Pacala. "As we look forward, the strength of our

    3/2/26 4:10:00 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    OppFi Announces its Fourth Quarter 2025 Earnings Conference Call

    CHICAGO, Feb. 26, 2026 /PRNewswire/ -- OppFi Inc. (NYSE:OPFI) ("OppFi" or the "Company"), a leading tech-enabled digital finance platform that works with banks to provide financial products and services for everyday Americans, will report financial results for its fourth quarter 2025 before the market open on Wednesday, March 11, 2026. Management will host a conference call on March 11, 2026, at 9:00 a.m. ET to discuss OppFi's financial results and business outlook. The conference call webcast will be available on the Investor Relations section of the Company's website at invest

    2/26/26 8:00:00 AM ET
    $OPFI
    Finance: Consumer Services
    Finance

    Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year

    First half fiscal 2026 revenue surpasses $2 million, up 36% year-over-year  Reader sales more than double to 104% year-over-year for the second quarter, demonstrating razor-razorblade model momentum Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, including $9.40 million receivable in connection with the private placement of securities that closed on January 2, 2026. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, no

    2/12/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Leadership Updates

    Live Leadership Updates

    View All

    Former Blue Bird CEO to Retire From Board

    Phil Horlock to Resign Following Successful CEO Transition Blue Bird Corporation (NASDAQ:BLBD), the leader in electric and clean-emission school buses, today announced that Phil Horlock, former Chief Executive Officer and a member of the company's Board of Directors, will be stepping down from the Board, effective immediately. Phil served as President & CEO of Blue Bird for more than 12 years, leading the organization through a period of transformative growth, operational excellence, and long-term value creation. Following his tenure as CEO, Phil remained on the Board after the appointment of John Wyskiel as President and CEO nearly one year ago. Horlock continued to provide strategic i

    12/29/25 4:02:00 PM ET
    $BLBD
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Ouster Appoints Phil Eyler to Board of Directors

    Mr. Eyler brings 30+ years of electronics, software and sensing expertise, particularly in the automotive industry, to the Company Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a global leader in high-performance lidar sensors and intelligent software solutions that bring Physical AI to life, announced today the appointment of Phillip M. Eyler to its Board of Directors. Mr. Eyler will also serve on the Compensation Committee of the Board. Mr. Eyler brings more than 30 years of engineering, operations, and business expertise to the Ouster Board, including a wealth of experience developing and selling hardware and software solutions for the automotive and industrial markets. He ha

    12/10/25 4:15:00 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Red Cat Announces Key Leadership Transitions

    SAN JUAN, Puerto Rico, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc. (NASDAQ:RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced two strategic leadership transitions designed to strengthen operational execution and financial performance as the Company accelerates growth. Christian Ericson, Red Cat's current Chief Financial Officer (CFO), has been promoted to the new role of Chief Operating Officer (COO). Ericson joined Red Cat in March 2025 as Chief Financial Officer and has played a pivotal role in advancing Red Cat's financial foundation and operational capabilities. In

    12/2/25 4:05:00 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    $ADXN
    $BBLN
    $BIOL
    $BLBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary